These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24516452)

  • 1. Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans.
    Routh MM; Chauhan NM; Karuppayil SM
    Braz J Microbiol; 2013; 44(3):855-9. PubMed ID: 24516452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with some anti-inflammatory drugs reduces germ tube formation in Candida albicans strains.
    Rusu E; Radu-Popescu M; Pelinescu D; Vassu T
    Braz J Microbiol; 2014; 45(4):1379-83. PubMed ID: 25763044
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Çolak A; Ikeh MAC; Nobile CJ; Baykara MZ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33148826
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
    Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
    [No Abstract]   [Full Text] [Related]  

  • 5. Gymnemic acids inhibit hyphal growth and virulence in Candida albicans.
    Vediyappan G; Dumontet V; Pelissier F; d'Enfert C
    PLoS One; 2013; 8(9):e74189. PubMed ID: 24040201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,4-Naphthoquinone derivatives potently suppress Candida albicans growth, inhibit formation of hyphae and show no toxicity toward zebrafish embryos.
    Janeczko M; Kubiński K; Martyna A; Muzyczka A; Boguszewska-Czubara A; Czernik S; Tokarska-Rodak M; Chwedczuk M; Demchuk OM; Golczyk H; Masłyk M
    J Med Microbiol; 2018 Apr; 67(4):598-609. PubMed ID: 29461185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of biofilm- and hyphal- development, two virulent features of Candida albicans by secondary metabolites of an endophytic fungus Alternaria tenuissima having broad spectrum antifungal potential.
    Chatterjee S; Ghosh R; Mandal NC
    Microbiol Res; 2020 Feb; 232():126386. PubMed ID: 31816593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of DNA topoisomerase inhibitors on Candida albicans.
    Kwok SC; Schelenz S; Wang X; Steverding D
    Med Mycol; 2010 Feb; 48(1):155-60. PubMed ID: 19626543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
    Lee JH; Kim YG; Lee J
    Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic Drugs Inhibit Growth, Dimorphism, and Biofilm Mode of Growth in Human Pathogen Candida albicans.
    Kathwate GH; Shinde RB; Karuppayil SM
    Assay Drug Dev Technol; 2015; 13(6):307-12. PubMed ID: 26241210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans.
    Larsen B; Petrovic M; De Seta F
    Mycopathologia; 2018 Apr; 183(2):349-357. PubMed ID: 28993976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis and dimorphism of azole-susceptible and resistant Candida albicans isolates.
    Costa CR; Hasimoto e Souza LK; Ataídes FS; Ferri PH; Costa MP; Fernanades Ode F; Silva Mdo R
    Rev Soc Bras Med Trop; 2011; 44(6):740-4. PubMed ID: 22094708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
    Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
    Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of inhibitors of yeast-to-hyphae transition in Candida albicans by a reporter screening assay.
    Heintz-Buschart A; Eickhoff H; Hohn E; Bilitewski U
    J Biotechnol; 2013 Mar; 164(1):137-42. PubMed ID: 23262131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
    Caldara M; Marmiroli N
    Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis.
    Bar-Yosef H; Vivanco Gonzalez N; Ben-Aroya S; Kron SJ; Kornitzer D
    Sci Rep; 2017 Jul; 7(1):5692. PubMed ID: 28720834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honey flavonoids inhibit Candida albicans morphogenesis by affecting DNA behavior and mitochondrial function.
    Canonico B; Candiracci M; Citterio B; Curci R; Squarzoni S; Mazzoni A; Papa S; Piatti E
    Future Microbiol; 2014; 9(4):445-56. PubMed ID: 24810344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer Drugs as Antibiofilm Agents in Candida albicans: Potential Targets.
    Wakharde AA; Halbandge SD; Phule DB; Karuppayil SM
    Assay Drug Dev Technol; 2018 Jul; 16(5):232-246. PubMed ID: 29446984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.
    Jadhav A; Bansode B; Phule D; Shelar A; Patil R; Gade W; Kharat K; Karuppayil SM
    World J Microbiol Biotechnol; 2017 May; 33(5):96. PubMed ID: 28409362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition.
    Zhao S; Huang JJ; Sun X; Huang X; Fu S; Yang L; Liu XW; He F; Deng Y
    Microb Biotechnol; 2018 Nov; 11(6):1080-1089. PubMed ID: 30221456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.